EnteraSense is a medical device sensor diagnostic company founded in 2015 and based in Europe’s leading MedTech cluster in Galway, Ireland. EnteraSense is committed to the innovation and commercialisation of GI sensor technologies. We aim to improve patient outcomes and transform the diagnosis and monitoring of Upper Gastrointestinal bleeding with our innovative sensor technology PillSenseTM. EnteraSense received FDA approval for their PillSenseTM sensor technology in February 2023. PillSenseTM is the First Blood Detection Capsule to be granted FDA DeNovo Market Clearance.